Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Distributed: Nationwide in the USAReason: Presence of Particulate Matter: Glass particulate matter detected in injectable.
Distributed: USA nationwide and Puerto RicoReason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Distributed: Nationwide in the USA.Reason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Distributed: Nationwide in the USA.Reason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Distributed: Nationwide in the USA.Reason: Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Distributed: Nationwide in the USA, Puerto Rico and CanadaReason: Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Distributed: Nationwide in the USA, Puerto Rico and CanadaReason: CGMP Deviations: potential for trace amounts of product carryover.
Distributed: Nationwide in the USAReason: CGMP Deviations: potential for trace amounts of product carryover.
Distributed: Nationwide in the USAReason: Short Fill
Distributed: Nationwide within the United States including Puerto Rico. Guatamala